Cite
HARVARD Citation
Hasegawa, A. et al. (2021). Mutated GM‐CSF‐based CAR‐T cells targeting CD116/CD131 complexes exhibit enhanced anti‐tumor effects against acute myeloid leukaemia. Clinical & translational immunology. 10 (5), p. n/a. [Online].